{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T03:00:54Z","timestamp":1773025254063,"version":"3.50.1"},"reference-count":75,"publisher":"Bentham Science Publishers Ltd.","issue":"11","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CTMC"],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Piperidines are among the essential synthetic fragments for designing\ndrugs and play a significant role in the pharmaceutical industry. The synthesis of newer derivatives\nby incorporating different amines paves the way for the introduction of novel drug combinations\nfor current cancer treatments.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Method:<\/jats:title>\n<jats:p>The new combinations of 1-(4-bromo-2-(pyrrolidine-1-yl) benzyl) piperidine derivatives\nwere synthesized by adding various amino groups. All the synthesized derivatives were characterized\nusing NMR and LC-MS. The anti-cancer activity of all the synthesized derivatives was studied\non three different cell lines, A549 (lung cancer), HCT-116 (colon cancer), and MCF-7(breast\ncancer), using an MTT assay. The most potent compounds, 7h and 7k were further evaluated for\ncell cycle and tubulin polymerization inhibitory activity. Further, in-silico analysis for the same\nproperties was performed using molecular docking using MM\/GBSA and validated by RMSD.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>All the synthesized derivatives showed selective cytotoxic potential against different cancer\ncell lines. Most of the derivatives displayed comparable anticancer potential in comparison to\n5-FU. The most potent derivative, 7h, further arrests the cancer cells in the G2\/M phase and prevents\ntubulin polymerization. The same was further confirmed using molecular docking on the\ncolchicine binding site.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>The derivative that arrests the cancer cells in the G2\/M phase of the cell cycle and\ninduces depolymerization can be developed as a good lead for further development.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0115680266336578241114072129","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:05:06Z","timestamp":1736143506000},"page":"1389-1402","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Design and Synthesis of 1-(4-Bromo-2-(Pyrrolidine-1-Yl) Benzyl) Piperidine-based Derivatives as Anti-tubulin Agents"],"prefix":"10.2174","volume":"25","author":[{"given":"Rambabu","family":"Guguloth","sequence":"first","affiliation":[{"name":"GITAM School of Pharmacy, GITAM Deemed to be University, Rudraram, Patancheru, Sanga Reddy, Telangana-\n502329, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiva Kumar","family":"Gubbiyappa","sequence":"additional","affiliation":[{"name":"GITAM School of Pharmacy, GITAM Deemed to be University, Rudraram, Patancheru, Sanga Reddy, Telangana-\n502329, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"2924","DOI":"10.1091\/mbc.e16-05-0271","volume":"28","author":"Chaaban S.","year":"2017","unstructured":"Chaaban S.; Brouhard G.J.; A microtubule bestiary: structural diversity in tubulin polymers. Mol Biol Cell  2017,28(22),2924-2931","journal-title":"Mol Biol Cell"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/s41580-021-00399-x","volume":"22","author":"Gudimchuk N.B.","year":"2021","unstructured":"Gudimchuk N.B.; McIntosh J.R.; Regulation of microtubule dynamics, mechanics and function through the growing tip. Nat Rev Mol Cell Biol  2021,22(12),777-795","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1146\/annurev.cellbio.16.1.89","volume":"16","author":"Downing K.H.","year":"2000","unstructured":"Downing K.H.; Structural basis for the interaction of tubulin with proteins and drugs that affect microtubule dynamics. Annu Rev Cell Dev Biol  2000,16(1),89-111","journal-title":"Annu Rev Cell Dev Biol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"127698","DOI":"10.1016\/j.bmcl.2020.127698","volume":"37","author":"Zhu T.","year":"2021","unstructured":"Zhu T.; Wang S.H.; Li D.; Wang S.Y.; Liu X.; Song J.; Wang Y.T.; Zhang S.Y.; Progress of tubulin polymerization activity detection methods. Bioorg Med Chem Lett  2021,37,127698","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"3425","DOI":"10.1242\/jcs.067611","volume":"123","author":"McIntosh J.R.","year":"2010","unstructured":"McIntosh J.R.; Volkov V.; Ataullakhanov F.I.; Grishchuk E.L.; Tubulin depolymerization may be an ancient biological motor. J Cell Sci  2010,123(20),3425-3434","journal-title":"J Cell Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1083\/jcb.201407095","volume":"207","author":"Brouhard G.J.","year":"2014","unstructured":"Brouhard G.J.; Rice L.M.; The contribution of\u03b1&#x3B2;-tubulin curvature to microtubule dynamics. J Cell Biol  2014,207(3),323-334","journal-title":"J Cell Biol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"713","DOI":"10.2174\/156800907783220480","volume":"7","author":"Braguer D.","year":"2007","unstructured":"Braguer D.; Carr&#xE9; M.; Esteve M-A.; Microtubules in apoptosis induction: are they necessary? Curr Cancer Drug Targ  2007,7(8),713-729","journal-title":"Curr Cancer Drug Targ"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"151075","DOI":"10.1016\/j.ejcb.2020.151075","volume":"99","author":"&#x10C;erm&#xE1;k V.","year":"2020","unstructured":"&#x10C;erm&#xE1;k V.; Dost&#xE1;l V.; Jel&#xED;nek M.; Libusov&#xE1; L.; Kov&#xE1;\u0159 J.; R&#xF6;sel D.; Br&#xE1;bek J.; Microtubule-targeting agents and their impact on cancer treatment. Eur J Cell Biol  2020,99(4),151075","journal-title":"Eur J Cell Biol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2015\/690916","volume":"2015","author":"Fanale D.","year":"2015","unstructured":"Fanale D.; Bronte G.; Passiglia F.; Cal&#xF2; V.; Castiglia M.; Di Piazza F.; Barraco N.; Cangemi A.; Catarella M.T.; Insalaco L.; List&#xEC; A.; Maragliano R.; Massihnia D.; Perez A.; Toia F.; Cicero G.; Bazan V.; Cangemi A.; Catarella M.T.; Insalaco L.; List&#xEC; A.; Maragliano R.; Massihnia D.; Perez A.; Toia F.; Cicero G.; Bazan V.; Stabilizing versus destabilizing the microtubules: a double-edge sword for an effective cancer treatment option? Anal Cell Pathol (Amst)  2015,2015(1),1-19","journal-title":"Anal Cell Pathol (Amst)"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"5650","DOI":"10.3390\/cancers13225650","volume":"13","author":"Wordeman L.","year":"2021","unstructured":"Wordeman L.; Vicente J.J.; Microtubule targeting agents in disease: classic drugs, novel roles. Cancers (Basel)  2021,13(22),5650","journal-title":"Cancers (Basel)"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.3390\/biom12121843","volume":"12","author":"Hawash M.","year":"2022","unstructured":"Hawash M.; Recent advances of tubulin inhibitors targeting the colchicine binding site for cancer therapy. Biomolecules  2022,12(12),1843","journal-title":"Biomolecules"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/B978-0-12-386033-0.00001-3","volume":"292","author":"Aylett C.H.S.","year":"2011","unstructured":"Aylett C.H.S.; L&#xF6;we J.; Amos L.A.; New insights into the mechanisms of cytomotive actin and tubulin filaments. Int Rev Cell Mol Biol  2011,292,1-71","journal-title":"Int Rev Cell Mol Biol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2174\/1568026619666190618130008","volume":"19","author":"Duan Y.","year":"2019","unstructured":"Duan Y.; Liu W.; Tian L.; Mao Y.; Song C.; Targeting tubulin-colchicine site for cancer therapy: inhibitors, antibody-drug conjugates and degradation agents. Curr Top Med Chem  2019,19(15),1289-1304","journal-title":"Curr Top Med Chem"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1021\/bi00118a015","volume":"31","author":"Skoufias D.A.","year":"1992","unstructured":"Skoufias D.A.; Wilson L.; Mechanism of inhibition of microtubule polymerization by colchicine: inhibitory potencies of unliganded colchicine and tubulin-colchicine complexes. Biochemistry  1992,31(3),738-746","journal-title":"Biochemistry"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"8","DOI":"10.3390\/ph13010008","volume":"13","author":"McLoughlin E.C.","year":"2020","unstructured":"McLoughlin E.C.; O\u2019Boyle N.M.; Colchicine-binding site inhibitors from chemistry to clinic: a review. Pharmaceuticals (Basel)  2020,13(1),8","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/sj.bjc.6605489","volume":"102","author":"Stengel C.","year":"2010","unstructured":"Stengel C.; Newman S.P.; Leese M.P.; Potter B.V.L.; Reed M.J.; Purohit A.; Class III\u03b2-tubulin expression and in vitro resistance to microtubule targeting agents. Br J Cancer  2010,102(2),316-324","journal-title":"Br J Cancer"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.2174\/1871520616666160219161921","volume":"16","author":"Wu X.","year":"2016","unstructured":"Wu X.; Wang Q.; Li W.; Recent advances in heterocyclic tubulin inhibitors targeting the colchicine binding site. Anticancer Agents Med Chem  2016,16(10),1325-1338","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1016\/S0021-9258(19)69153-2","volume":"256","author":"Ray K.","year":"1981","unstructured":"Ray K.; Bhattacharyya B.; Biswas B.B.; Role of B-ring of colchicine in its binding to tubulin. J Biol Chem  1981,256(12),6241-6244","journal-title":"J Biol Chem"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"839","DOI":"10.4155\/fmc-2020-0376","volume":"13","author":"Sun K.","year":"2021","unstructured":"Sun K.; Sun Z.; Zhao F.; Shan G.; Meng Q.; Recent advances in research of colchicine binding site inhibitors and their interaction modes with tubulin. Future Med Chem  2021,13(9),839-858","journal-title":"Future Med Chem"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"116976","DOI":"10.1016\/j.bmc.2022.116976","volume":"72","author":"Dwivedi A.R.","year":"2022","unstructured":"Dwivedi A.R.; Rawat S.S.; Kumar V.; Kumar N.; Anand P.; Yadav R.P.; Baranwal S.; Prasad A.; Kumar V.; Chemistry M.; Synthesis and screening of novel 4-N-heterocyclic-2-aryl-6,7,8-trimethoxyquinazolines as antiproliferative and tubulin polymerization inhibitors. Bioorg Med Chem  2022,72,116976","journal-title":"Bioorg Med Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.2174\/1568009623666221028121906","volume":"23","author":"Prasad A.","year":"2023","unstructured":"Prasad A.; Kumar V.; Dwivedi A.R.; Rawat S.S.; Kumar V.; Kumar N.; Kumar V.; Yadav R.P.; Baranwal S.; Benzotriazole Substituted 2-Phenylquinazolines as Anticancer Agents: Synthesis, Screening, Antiproliferative and Tubulin Polymerization Inhibition Activity. Curr Cancer Drug Targets  2023,23(4),278-292","journal-title":"Curr Cancer Drug Targets"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.3390\/ijms24032937","volume":"24","author":"Frolov N.A.","year":"2023","unstructured":"Frolov N.A.; Vereshchagin A.N.; Piperidine derivatives: recent advances in synthesis and pharmacological applications. Int J Mol Sci  2023,24(3),2937","journal-title":"Int J Mol Sci"},{"key":"ref=23","first-page":"109855","author":"Sun W.","year":"2024","unstructured":"Sun W.; Liao A.; Lei L.; Tang X.; Wang Y.; Wu J.; Research progress on piperidine-containing compounds as agrochemicals. Chin Chem Lett  2024,109855","journal-title":"Chin Chem Lett"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1007\/BF00771998","volume":"25","author":"Kurbat N.M.","year":"1991","unstructured":"Kurbat N.M.; Praliev K.D.; Salita T.A.; Yu V.K.; Verina E.L.; Neuropharmacological activity of piperidine derivatives (a review). Pharm Chem J  1991,25(7),450-462","journal-title":"Pharm Chem J"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s43094-021-00335-y","volume":"7","author":"Abdelshaheed M.M.","year":"2021","unstructured":"Abdelshaheed M.M.; Fawzy I.M.; El-Subbagh H.I.; Youssef K.M.; Piperidine nucleus in the field of drug discovery. Future J Pharm Sci  2021,7(1),188","journal-title":"Future J Pharm Sci"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"37731","DOI":"10.1021\/acsomega.3c05883","volume":"8","author":"Jayan J.","year":"2023","unstructured":"Jayan J.; Chandran N.; Thekkantavida A.C.; Abdelgawad M.A.; Ghoneim M.M.; Shaker M.E.; Uniyal P.; Benny F.; Zachariah S.M.; Kumar S.; Kim H.; Mathew B.; Piperidine: A Versatile Heterocyclic Ring for Developing Monoamine Oxidase Inhibitors. ACS Omega  2023,8(41),37731-37751","journal-title":"ACS Omega"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.ejmech.2018.08.017","volume":"157","author":"Goel P.","year":"2018","unstructured":"Goel P.; Alam O.; Naim M.J.; Nawaz F.; Iqbal M.; Alam M.I.; Recent advancement of piperidine moiety in treatment of cancer- A review. Eur J Med Chem  2018,157,480-502","journal-title":"Eur J Med Chem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"29316","DOI":"10.1039\/D3RA06115A","volume":"13","author":"Lei Y.","year":"2023","unstructured":"Lei Y.; Li B.; Liao X.; Xing X.; Feng P.; Zhao B.; Xu S.; Isolation and total synthesis of dysidone A: a new piperidone alkaloid from the marine sponge Dysidea sp. RSC Advances  2023,13(42),29316-29319","journal-title":"RSC Advances"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1055\/s-0037-1611715","volume":"51","author":"D\u2019hooghe M.","year":"2019","unstructured":"D\u2019hooghe M.; Ha H-J.; Macha L.; Deployment of aziridines for the synthesis of alkaloids and their derivatives. Synthesis  2019,51(7),1491-1515","journal-title":"Synthesis"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"772418","DOI":"10.3389\/fphar.2021.772418","volume":"12","author":"Mitra S.","year":"2022","unstructured":"Mitra S.; Anand U.; Jha N.K.; Shekhawat M.S.; Saha S.C.; Nongdam P.; Rengasamy K.R.R.; Pro\u0107k&#xF3;w J.; Dey A.; Anticancer applications and pharmacological properties of piperidine and piperine: a comprehensive review on molecular mechanisms and therapeutic perspectives. Front Pharmacol  2022,12,772418","journal-title":"Front Pharmacol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3390\/biomedicines10010154","volume":"10","author":"Azam S.","year":"2022","unstructured":"Azam S.; Park J.Y.; Kim I.S.; Choi D.K.; Piperine and its metabolite\u2019s pharmacology in neurodegenerative and neurological diseases. Biomedicines  2022,10(1),154","journal-title":"Biomedicines"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.ejmech.2014.11.041","volume":"90","author":"Sharma R.","year":"2015","unstructured":"Sharma R.; Soman S.S.; Design and synthesis of sulfonamide derivatives of pyrrolidine and piperidine as anti-diabetic agents. Eur J Med Chem  2015,90,342-350","journal-title":"Eur J Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"10326","DOI":"10.1016\/j.bmc.2008.10.042","volume":"16","author":"Weis R.","year":"2008","unstructured":"Weis R.; Schweiger K.; Faist J.; Rajkovic E.; Kungl A.J.; Fabian W.M.F.; Schunack W.; Seebacher W.; Antimycobacterial and H1-antihistaminic activity of 2-substituted piperidine derivatives. Bioorg Med Chem  2008,16(24),10326-10331","journal-title":"Bioorg Med Chem"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"2000354","DOI":"10.1002\/ardp.202000354","volume":"354","author":"Buran K.","year":"2021","unstructured":"Buran K.; Reis R.; Sipahi H.;\u00d6nen Bayram F.E.; Piperazine and piperidine\u2010substituted 7\u2010hydroxy coumarins for the development of anti\u2010inflammatory agents. Arch Pharm (Weinheim)  2021,354(7),2000354","journal-title":"Arch Pharm (Weinheim)"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"135832","DOI":"10.1016\/j.molstruc.2023.135832","volume":"1289","author":"Janani S.","year":"2023","unstructured":"Janani S.; Rajagopal H.; Sakthivel S.; Kadaikunnan S.; Abbas G.; Muthu S.; Comparison of experimental and theoretical spectral groups, electronic properties, topological, and molecular docking investigations of 1-N-Cbz-piperidine-4-carboxylic acid- Potential Cancer drug. J Mol Struct  2023,1289,135832","journal-title":"J Mol Struct"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1002\/cncr.33587","volume":"127","author":"Bray F.","year":"2021","unstructured":"Bray F.; Laversanne M.; Weiderpass E.; Soerjomataram I.; The ever\u2010increasing importance of cancer as a leading cause of premature death worldwide. Cancer  2021,127(16),3029-3030","journal-title":"Cancer"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1002\/ptr.7291","volume":"36","author":"Quijia C.R.","year":"2022","unstructured":"Quijia C.R.; Chorilli M.; Piperine for treating breast cancer: A review of molecular mechanisms, combination with anticancer drugs, and nanosystems. Phytother Res  2022,36(1),147-163","journal-title":"Phytother Res"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"4918","DOI":"10.2174\/0929867324666170523120656","volume":"25","author":"Manayi A.","year":"2019","unstructured":"Manayi A.; Nabavi S.M.; Setzer W.N.; Jafari S.; Piperine as a potential anti-cancer agent: a review on preclinical studies. Curr Med Chem  2019,25(37),4918-4928","journal-title":"Curr Med Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s43088-022-00196-1","volume":"11","author":"Tripathi A.K.","year":"2022","unstructured":"Tripathi A.K.; Ray A.K.; Mishra S.K.; Molecular and pharmacological aspects of piperine as a potential molecule for disease prevention and management: evidence from clinical trials. Beni Suef Univ J Basic Appl Sci  2022,11(1),16","journal-title":"Beni Suef Univ J Basic Appl Sci"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"75","DOI":"10.2174\/1874842201603010075","volume":"3","author":"Chopra B.","year":"2016","unstructured":"Chopra B.; Dhingra A.K.; Kapoor R.P.; Prasad D.N.; Piperine and its various physicochemical and biological aspects: A review. Open Chem J  2016,3(1),75-96","journal-title":"Open Chem J"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"156","DOI":"10.2174\/1573407211666150915214425","volume":"11","author":"Chinta G.","year":"2015","unstructured":"Chinta G.; Syed B.S.; Coumar M.S.; Periyasamy L.; Piperine: A comprehensive review of pre-clinical and clinical investigations. Curr Bioact Compd  2015,11(3),156-169","journal-title":"Curr Bioact Compd"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"5466","DOI":"10.1007\/s00044-013-0541-4","volume":"22","author":"Umadevi P.","year":"2013","unstructured":"Umadevi P.; Deepti K.; Venugopal D.V.R.; Synthesis, anticancer and antibacterial activities of piperine analogs. Med Chem Res  2013,22(11),5466-5471","journal-title":"Med Chem Res"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.phymed.2011.06.031","volume":"19","author":"Li S.","year":"2011","unstructured":"Li S.; Lei Y.; Jia Y.; Li N.; Wink M.; Ma Y.; Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine  2011,19(1),83-87","journal-title":"Phytomedicine"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"5617","DOI":"10.1007\/s11033-019-04927-z","volume":"46","author":"Zadorozhna M.","year":"2019","unstructured":"Zadorozhna M.; Tataranni T.; Mangieri D.; Piperine: role in prevention and progression of cancer. Mol Biol Rep  2019,46(5),5617-5629","journal-title":"Mol Biol Rep"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"e230124226013","DOI":"10.2174\/0115734072276134231130170407","volume":"20","author":"Mishra P.S.","year":"2024","unstructured":"Mishra P.S.; Kaushik N.; Mishra R.; Koul S.; Sagar S.; Natural Alkaloids and Mechanisms for Anti-cancer Action: A Review. Curr Bioact Compd  2024,20(8),e230124226013","journal-title":"Curr Bioact Compd"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0031-9422(03)00111-0","volume":"63","author":"Dragull K.","year":"2003","unstructured":"Dragull K.; Yoshida W.Y.; Tang C.S.; Piperidine alkaloids from Piper methysticum. Phytochemistry  2003,63(2),193-198","journal-title":"Phytochemistry"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"114954","DOI":"10.1016\/j.ejmech.2022.114954","volume":"246","author":"Bhat A.A.","year":"2023","unstructured":"Bhat A.A.; Singh I.; Tandon N.; Tandon R.; Structure activity relationship (SAR) and anticancer activity of pyrrolidine derivatives: Recent developments and future prospects (A review). Eur J Med Chem  2023,246,114954","journal-title":"Eur J Med Chem"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.2174\/1871520622666220324102849","volume":"22","author":"Alrooqi M.","year":"2022","unstructured":"Alrooqi M.; Khan S.; Alhumaydhi F.A.; Asiri S.A.; Alshamrani M.; Mashraqi M.M.; Alzamami A.; Alshahrani A.M.; Aldahish A.A.; A therapeutic journey of pyridine-based heterocyclic compounds as potent anticancer agents: a review (from 2017 to 2021). Anticancer Agents Med Chem  2022,22(15),2775-2787","journal-title":"Anticancer Agents Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.2174\/1570180811666140623204022","volume":"11","author":"Yuan Y.P.","year":"2014","unstructured":"Yuan Y.P.; Wang S.B.; Gong G.H.; Quan Z.S.; Synthesis and Studies on Anticonvulsant and Antibacterial Activities of 1- Alkyl-4-(4H-1,2,4-triazol-4-yl)piperidine Derivatives. Lett Drug Des Discov  2014,11(9),1070-1078","journal-title":"Lett Drug Des Discov"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"137","DOI":"10.31083\/j.fbl2704137","volume":"27","author":"Lim J.S.","year":"2022","unstructured":"Lim J.S.; Lee D.Y.; Lim J.H.; Oh W.K.; Park J.T.; Park S.C.; Cho K.A.; Piperine: an anticancer and senostatic drug. Front Biosci (Landmark Ed)  2022,27(4),137","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.3390\/ijms22084243","volume":"22","author":"Wojtowicz K.","year":"2021","unstructured":"Wojtowicz K.; Sterzy\u0144ska K.;\u015awierczewska M.; Nowicki M.; Zabel M.; Januchowski R.; Piperine targets different drug resistance mechanisms in human ovarian cancer cell lines leading to increased sensitivity to cytotoxic drugs. Int J Mol Sci  2021,22(8),4243","journal-title":"Int J Mol Sci"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1590\/S0100-879X2006000600014","volume":"39","author":"Bezerra D.P.","year":"2006","unstructured":"Bezerra D.P.; Castro F.O.; Alves A.P.N.N.; Pessoa C.; Moraes M.O.; Silveira E.R.; Lima M.A.S.; Elmiro F.J.M.; Costa-Lotufo L.V.; In vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from Piper. Braz J Med Biol Res  2006,39(6),801-807","journal-title":"Braz J Med Biol Res"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"110247","DOI":"10.1016\/j.biopha.2020.110247","volume":"128","author":"Ferreira R.C.","year":"2020","unstructured":"Ferreira R.C.; Batista T.M.; Duarte S.S.; Silva D.K.F.; Lisboa T.M.H.; Cavalcanti R.F.P.; Leite F.C.; Mangueira V.M.; Sousa T.K.G.; Abrantes R.A.; Trindade E.O.; Athayde-Filho P.F.; Brand&#xE3;o M.C.R.; Medeiros K.C.P.; Farias D.F.; Sobral M.V.; A novel piperine analogue exerts in vivo antitumor effect by inducing oxidative, antiangiogenic and immunomodulatory actions. Biomed Pharmacother  2020,128,110247","journal-title":"Biomed Pharmacother"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"598389","DOI":"10.3389\/fbioe.2020.598389","volume":"8","author":"Kirsch M.","year":"2021","unstructured":"Kirsch M.; Rach J.; Handke W.; Seltsam A.; Pepelanova I.; Strau&#xDF; S.; Vogt P.; Scheper T.; Lavrentieva A.; Comparative analysis of mesenchymal stem cell cultivation in fetal calf serum, human serum, and platelet lysate in 2D and 3D systems. Front Bioeng Biotechnol  2021,8,598389","journal-title":"Front Bioeng Biotechnol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1093\/jnci\/djt007","volume":"105","author":"Gillet J.P.","year":"2013","unstructured":"Gillet J.P.; Varma S.; Gottesman M.M.; The clinical relevance of cancer cell lines. J Natl Cancer Inst  2013,105(7),452-458","journal-title":"J Natl Cancer Inst"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13065-022-00893-z","volume":"16","author":"Emami L.","year":"2022","unstructured":"Emami L.; Khabnadideh S.; Faghih Z.; Farahvasi F.; Zonobi F.; Gheshlaghi S.Z.; Daili S.; Ebrahimi A.; Faghih Z.; Synthesis, biological evaluation, and computational studies of some novel quinazoline derivatives as anticancer agents. BMC Chem  2022,16(1),100","journal-title":"BMC Chem"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1385\/1-59259-811-0:301","volume":"281","author":"Pozarowski P.","year":"2004","unstructured":"Pozarowski P.; Darzynkiewicz Z.; Activation C.V.; Protocols R.; Analysis of cell cycle by flow cytometry. Methods Mol Biol  2004,281,301-312","journal-title":"Methods Mol Biol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.bioorg.2018.02.027","volume":"78","author":"Kumar B.","year":"2018","unstructured":"Kumar B.; Sharma P.; Gupta V.P.; Khullar M.; Singh S.; Dogra N.; Kumar V.; Synthesis and biological evaluation of pyrimidine bridged combretastatin derivatives as potential anticancer agents and mechanistic studies. Bioorg Chem  2018,78,130-140","journal-title":"Bioorg Chem"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"489","DOI":"10.14233\/ajchem.2024.31036","volume":"36","author":"Guguloth R.","year":"2024","unstructured":"Guguloth R.; Gubbiyappa S.K.; Synthesis, Docking and Biological Evaluation of New Series of Pyrrolidine Derivatives as Potent Antibacterial Agents. Asian J Chem  2024,36(2),489-497","journal-title":"Asian J Chem"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1039\/D2MD00023G","volume":"13","author":"Dwivedi A.R.","year":"2022","unstructured":"Dwivedi A.R.; Kumar V.; Prashar V.; Verma A.; Kumar N.; Parkash J.; Kumar V.; Morpholine substituted quinazoline derivatives as anticancer agents against MCF-7, A549 and SHSY-5Y cancer cell lines and mechanistic studies. RSC Med Chem  2022,13(5),599-609","journal-title":"RSC Med Chem"},{"key":"ref=61","first-page":"165","volume":"88","author":"Plumb J.A.","year":"2004","unstructured":"Plumb J.A.; Cell sensitivity assays: the MTT assay. Methods Mol Med  2004,88,165-169","journal-title":"Methods Mol Med"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1002\/med.21634","volume":"40","author":"Kourounakis A.P.","year":"2020","unstructured":"Kourounakis A.P.; Xanthopoulos D.; Tzara A.; Morpholine as a privileged structure: A review on the medicinal chemistry and pharmacological activity of morpholine containing bioactive molecules. Med Res Rev  2020,40(2),709-752","journal-title":"Med Res Rev"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/CAD.0000000000000464","volume":"28","author":"Kumar A.","year":"2017","unstructured":"Kumar A.; Sharma P.R.; Mondhe D.M.; Potential anticancer role of colchicine-based derivatives. Anticancer Drugs  2017,28(3),250-262","journal-title":"Anticancer Drugs"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"112308","DOI":"10.1016\/j.ejmech.2020.112308","volume":"197","author":"Shuai W.","year":"2020","unstructured":"Shuai W.; Li X.; Li W.; Xu F.; Lu L.; Yao H.; Yang L.; Zhu H.; Xu S.; Zhu Z.; Xu J.; Design, synthesis and anticancer properties of isocombretapyridines as potent colchicine binding site inhibitors. Eur J Med Chem  2020,197,112308","journal-title":"Eur J Med Chem"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.molcel.2011.11.014","volume":"44","author":"Varetti G.","year":"2011","unstructured":"Varetti G.; Guida C.; Santaguida S.; Chiroli E.; Musacchio A.; Homeostatic control of mitotic arrest. Mol Cell  2011,44(5),710-720","journal-title":"Mol Cell"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/cbf.3166","volume":"34","author":"Kumar A.","year":"2016","unstructured":"Kumar A.; Singh B.; Sharma P.R.; Bharate S.B.; Saxena A.K.; Mondhe D.M.; A novel microtubule depolymerizing colchicine analogue triggers apoptosis and autophagy in HCT\u2010116 colon cancer cells. Cell Biochem Funct  2016,34(2),69-81","journal-title":"Cell Biochem Funct"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.2174\/0929867330666230622142505","volume":"31","author":"Cui Y.","year":"2024","unstructured":"Cui Y.; Zhang J.; Zhang G.; The Potential Strategies for Overcoming Multidrug Resistance and Reducing Side Effects of Monomer Tubulin Inhibitors for Cancer Therapy. Curr Med Chem  2024,31(14),1874-1895","journal-title":"Curr Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"104191","DOI":"10.1016\/j.bioorg.2020.104191","volume":"103","author":"Donthiboina K.","year":"2020","unstructured":"Donthiboina K.; Anchi P.; Gurram S.; Sai Mani G.; Lakshmi Uppu J.; Godugu C.; Shankaraiah N.; Kamal A.; Synthesis and biological evaluation of substituted N-(2-(1H-benzo[d]imidazol-2-yl)phenyl)cinnamides as tubulin polymerization inhibitors. Bioorg Chem  2020,103,104191","journal-title":"Bioorg Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.sjbs.2020.10.023","volume":"28","author":"Sahayarayan J.J.","year":"2021","unstructured":"Sahayarayan J.J.; Rajan K.S.; Vidhyavathi R.; Nachiappan M.; Prabhu D.; Alfarraj S.; Arokiyaraj S.; Daniel A.N.; In-silico protein-ligand docking studies against the estrogen protein of breast cancer using pharmacophore based virtual screening approaches. Saudi J Biol Sci  2021,28(1),400-407","journal-title":"Saudi J Biol Sci"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"9478","DOI":"10.1021\/acs.chemrev.9b00055","volume":"119","author":"Wang E.","year":"2019","unstructured":"Wang E.; Sun H.; Wang J.; Wang Z.; Liu H.; Zhang J.Z.H.; Hou T.; End-point binding free energy calculation with MM\/PBSA and MM\/GBSA: strategies and applications in drug design. Chem Rev  2019,119(16),9478-9508","journal-title":"Chem Rev"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.4155\/fmc-2017-0100","volume":"9","author":"Li W.","year":"2017","unstructured":"Li W.; Sun H.; Xu S.; Zhu Z.; Xu J.; Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures. Future Med Chem  2017,9(15),1765-1794","journal-title":"Future Med Chem"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"110312","DOI":"10.1016\/j.cbi.2022.110312","volume":"370","author":"&#x15E;ahin \u0130.","year":"2023","unstructured":"&#x15E;ahin \u0130.;\u00c7e&#x15F;me M.;\u00d6zgeri&#x15F; F.B.; T&#xFC;mer F.; Triazole based novel molecules as potential therapeutic agents: Synthesis, characterization, biological evaluation, in-silico ADME profiling and molecular docking studies. Chem Biol Interact  2023,370,110312","journal-title":"Chem Biol Interact"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1080\/10799893.2016.1217883","volume":"37","author":"Malik R.","year":"2017","unstructured":"Malik R.; Mehta P.; Srivastava S.; Choudhary B.S.; Sharma M.; Pharmacophore modeling, 3D-QSAR, and in silico ADME prediction of N -pyridyl and pyrimidine benzamides as potent antiepileptic agents. J Recept Signal Transduct Res  2017,37(3),259-266","journal-title":"J Recept Signal Transduct Res"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1517\/17460441.2012.714363","volume":"7","author":"Arnott J.A.","year":"2012","unstructured":"Arnott J.A.; Planey S.L.; The influence of lipophilicity in drug discovery and design. Expert Opin Drug Discov  2012,7(10),863-875","journal-title":"Expert Opin Drug Discov"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1021\/op700130z","volume":"12","author":"Kokitkar P.B.","year":"2008","unstructured":"Kokitkar P.B.; Plocharczyk E.; Chen C.C.; Modeling drug molecule solubility to identify optimal solvent systems for crystallization. Org Process Res Dev  2008,12(2),249-256","journal-title":"Org Process Res Dev"}],"container-title":["Current Topics in Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266336578241114072129","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/237961\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0115680266336578241114072129","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T04:33:16Z","timestamp":1751517196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/237961\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":75,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0115680266336578241114072129","relation":{},"ISSN":["1568-0266"],"issn-type":[{"value":"1568-0266","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-07-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-29","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-10-16","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}